Home » Trials » SLCTR/2023/023


Effectiveness of a behavior change intervention package on health literacy of behavioural risk factors of non-communicable diseases among health care assistants of government hospitals in Colombo district: Cluster randomized controlled trial

-

SLCTR Registration Number

SLCTR/2023/023


Date of Registration

11 Dec 2023

The date of last modification

Jan 31, 2024



Application Summary


Scientific Title of Trial

Effectiveness of a behavior change intervention package on health literacy of behavioural risk factors of non-communicable diseases among health care assistants of government hospitals in Colombo district: Cluster randomized controlled trial


Public Title of Trial

Effectiveness of a behavior change intervention package on health literacy of behavioural risk factors of non-communicable diseases among health care assistants of government hospitals in Colombo district: Cluster randomized controlled trial.


Disease or Health Condition(s) Studied

Health Literacy


Scientific Acronym

None


Public Acronym

None


Brief title

Effectiveness of a behavior change intervention package in improving health literacy on behavioural risk factors of non-communicable diseases among health care assistants of government hospitals in Colombo district


Universal Trial Number

U1111-1299-4066


Any other number(s) assigned to the trial and issuing authority

ERC: EC/23/061 Ethics Review Committee Faculty of Medicine University of Colombo


Trial Details


What is the research question being addressed?

Can a Behavior Change Intervention Package (BCIP), improve, health literacy based on Calgary charter, among Health Care Assistant (HCAs) of government hospitals in Colombo district


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Single blinded : Data analysts, Outcome assessors


Control

Standard therapy/practice


Assignment

Parallel


Purpose

Prevention


Study Phase

Not Applicable


Intervention(s) planned

a) Study design: Cluster randomized controlled trial

b) Study setting: This study will be conducted in hospitals in Colombo district (Hospitals in Colombo district attached as annexure III)

c) Study population: Health care assistants working in government hospitals in Colombo district

d). Randomization: - Ten units per arm (Intervention and control arm) - Generating a random allocation sequence using a random number table - Allocation concealment: Twenty Hospitals will be selected using stratified cluster sampling method based on type of hospitals in Colombo district. Each hospital will be taken as cluster and there will be twenty clusters (hospitals).

Hospitals will be allocated to the intervention and the control groups by an independent person (Consultant Community Physician attached to MoH), who will not be involved in selection of participants, or any other activity related to this study (Concealment of allocation).

Required number of HCAs will be selected randomly from the pay roll of all HCAs attached to the hospital. It will be selected in three steps within the hospital. Step I: All HCAs will be listed out based on pay roll. Step II: Eligible HCAs will be selected based on inclusion and exclusion criteria. Step III: Required number of HCAs will be selected using simple random sampling (random table).

Intervention: Behaviour change Intervention Package (BCIP) will be delivered to the participants of the intervention arm. This package includes multiple interventions such as lectures, role playing sessions, brainstorming sessions, and small group discussions. This package will be delivered as two sessions per week for 8 weeks, total of sixteen sessions. Further it consists of Curriculum, Facilitator guide, Participants’ handbook, and Power point presentation for sixteen sessions in three mediums. (Curriculum is attached – Annex IV)

Control: Control group will only have the exposure to routine health system inputs and no intervention will be given. (Flow chart is attached – Annex V)

Healthcare providers and Data analysts will be blinded


Inclusion criteria

  • Permanent staff who have been working as HCA more than six months
  • Age of HCAs would be in between 18 years to 45 years.
  • Both male and female

Exclusion criteria

  • Staff who plan to retire or transfer within a year
  • HCAs who are on long leave e.g. : maternity leave or medical leave
  • HCAs who are already diagnosed with a NCD, verified by diagnosis card or clinic book
  • HCAs in PMCUs of Colombo district


Primary outcome(s)

1.

HL.NCD: Health Literacy tool to assess NCD behavioral risk factors. It was developed and validated in the first component of this research.

[

12 weeks from initial assessment

]

Secondary outcome(s)

1.

Secondary outcomes are behaviour change of pattern/frequency of Diet, frequency of physical activity, status/frequency of tobacco use and status/frequency of alcohol intake. It will be measured using STEP-wise-approach-toSurveillance (STEPS) of NCD risk factor questionnaire.

[

12 weeks from initial assessment

]

Target number/sample size

240 - 120 in each arm


Countries of recruitment

Sri Lanka


Anticipated start date

2023-12-15


Anticipated end date

2024-07-31


Date of first enrollment

2023-12-15


Date of study completion


Recruitment status

Recruiting


Funding source

None


Regulatory approvals

Not applicable



State of Ethics Review Approval


Status

Approved


Date of Approval

2023-09-21


Approval number

EC-23-061


Details of Ethics Review Committee

Name: Ethics Review Committee Faculty of Medicine University of Colombo
Institutional Address:P O Box 271, Kynsey Road, Colombo 8, Sri Lanka
Telephone:Telephone: +94-11-2695300 ext 240 Fax: +94-11-2691581
Email: ethicscommitteemfc@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr M.M.M. Irshad
Registrar in Community Medicine
Directorate of NCD, Ministry of Health
0773566565
0712747300

irshadim21@gmail.com

Contact Person for Public Queries

Dr. Dulani Samaranayake
Senior Lecturer
Department of Community Medicine, Faculty of Medicine, University of Colombo, Sri Lanka
+94- 071-6613296


dulani_samaranayake@yahoo.com


Primary study sponsor/organization

Directorate of Non Communicable diseases, Ministry of Health Sri Lanka.

385 Ven. Baddegama Wimalawansa Thero Mawatha, Maradana, Colombo
(94) 112 694033

info(at)health.gov.lk

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?

Yes


IPD sharing plan description

Individual participant data that underlie the results being reported, after deidentification (text, tables, figures, and appendices) Data will be shared with investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available at the University data warehouse but without investigator support other than deposited meta-data. Information regarding submitting proposals and accessing data may be found at irshadim21@gmail.com.


Study protocol available

No


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results